Back

Intra-Cellular Therapies Stock Predictions

Escape the market madness with 7 stocks to buy and hold

Get the complete list FREE for a limited time.

Sell

ITCI
Intra-Cellular Therapies

Last Price:

77.09

Seasonality Move:

27.94%

7 Day Trial

ALL ACCESS PASS

$ 7

The truth about AI stocks (must see)

Learn the names of all 10 stocks here. FREE.

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 42.5% based on the past 10 years of stock performance.
Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $77.09. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 42.5% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

84.89

52-Week Low:

45.50

Prediction Charts

Market Cap:

8.15B

Price in USD:

77.09

Volume:

321.7K

Beta:

1.06

Technical Analysis

SMA50:

74.47

SMA100:

73.95

SMA200:

71.38

52-Wk Change:

54%

Stock Predictions

Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 77.09 USD today.
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Oct-2	72.30	72.63	73.34	71.82
Oct-3	72.53	72.27	73.31	72.21
Oct-4	72.71	72.89	72.97	72.32
Oct-7	72.90	71.19	73.18	70.90
Oct-8	71.43	72.38	72.71	71.20
Oct-9	72.68	73.25	74.32	72.32
Oct-10	73.10	73.61	73.71	71.95
Oct-11	73.70	75.76	76.19	73.70
Oct-14	76.02	73.84	76.14	73.76
Oct-15	73.91	74.71	75.12	73.82
Oct-16	75.10	76.09	76.55	74.59
Oct-18	78.22	78.34	79.46	78.04
Oct-21	77.94	76.91	78.47	76.56
Oct-22	76.52	77.09	78.03	76.17

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $1.12 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.